Label: SENNA-S tablet

  • NDC Code(s): 72090-030-20
  • Packager: Pioneer Life Sciences, LLC
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated November 26, 2024

If you are a consumer or patient please visit this version.

  • Active Ingredients (in each tablet)

    Docusate Sodium 50 mg

    Sennosides 8.6 mg

  • Purpose

    Stool softener

    Laxative

  • Uses:

    • Relieves occasional constipation (irregularity).
    • Generally produces a bowel movement in 6 to 12 hours.
  • Warnings:

    Do not use: If you are now taking mineral oil, unless directed by a doctor. Laxative products for longer than 1 week, unless directed by a doctor.

  • ASK DOCTOR

    Ask a doctor before use if you have: 

    • Stomach pain
    • nausea
    • vomiting
    • Noticed a sudden change in bowel habits that continues over a period of 2 weeks.
  • STOP USE

    Stop use and ask a doctor if you have:

    • Rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.
  • PREGNANCY OR BREAST FEEDING

    • If pregnant or breast-feeding, ask a health professional before use.
  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

  • DIRECTIONS

    Take preferably at bedtime or as directed by a doctor.

    age

    starting dosage

    maximum dosage

    adults & children 12 years of age and over

    2 tablets once a day

    4 tablets twice a day

    children 6 to under 12 years

    1 tablet once a day

    2 tablets twice a day

    children 2 to under 6 years

    1 /2 tablet once a day

    1 tablet twice a day

    children under 2 years

    ask a doctor

    ask a doctor

  • OTHER INFORMATION

    • Each tablet contains: Calcium 19.92 mg, Sodium 5.61 mg VERY LOW SODIUM
    • store at 25°C (77°F) excursions permitted between15°-30°C (59°-86°F)
  • INACTIVE INGREDIENTS

    Croscarmellose Sodium, Colloidal Silicon Dioxide, Dicalcium Phosphate, F D & C Red, Hypromellose, Magnesium Stearate,
    Microcrystalline Cellulose, Maltodextrin, Polyethylene Glycol, Stearic acid Powder, Titanium Dioxide.

  • QUESTIONS OR COMMENTS?

    Call toll-free 1 (732) 689-5070 Monday through Friday 9 am to 5 pm EST.

  • PRINCIPAL DISPLAY PANEL

    Senna-S-Senokot-200ct.jpg

  • INGREDIENTS AND APPEARANCE
    SENNA-S 
    senna-s tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72090-030
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM50 mg
    SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
    Inactive Ingredients
    Ingredient NameStrength
    Croscarmellose Sodium (UNII: M28OL1HH48)  
    Silicon Dioxide (UNII: ETJ7Z6XBU4)  
    ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J)  
    FD&C RED NO. 3 (UNII: PN2ZH5LOQY)  
    HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
    Magnesium Stearate (UNII: 70097M6I30)  
    Microcrystalline Cellulose (UNII: OP1R32D61U)  
    Maltodextrin (UNII: 7CVR7L4A2D)  
    POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    Titanium Dioxide (UNII: 15FIX9V2JP)  
    Product Characteristics
    ColorredScoreno score
    ShapeROUNDSize10mm
    FlavorImprint Code none
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:72090-030-20200 in 1 BOTTLE; Type 0: Not a Combination Product06/29/2020
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph Drug505G(a)(3)06/29/2020
    Labeler - Pioneer Life Sciences, LLC (014092742)
    Registrant - Pioneer Life Sciences, LLC (014092742)